• 1867 Citations
  • 25 h-Index
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kenzo Soejima is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1867 Citations
  • 25 h-Index
  • 114 Article
  • 2 Review article
  • 1 Short survey

Gefitinib alone versus gefitinib plus chemotherapy for non–small-cell lung cancer with mutated epidermal growth factor receptor: NEJ009 study

North-East Japan Study Group, 2020, In : Journal of Clinical Oncology. 38, 2, p. 115-123 9 p.

Research output: Contribution to journalArticle

  • 22 Citations (Scopus)

    Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small-cell lung cancer cells

    Ohgino, K., Terai, H., Yasuda, H., Nukaga, S., Hamamoto, J., Tani, T., Kuroda, A., Arai, D., Ishioka, K., Masuzawa, K., Ikemura, S., Kawada, I., Naoki, K., Fukunaga, K. & Soejima, K., 2020, (Accepted/In press) In : Cancer science.

    Research output: Contribution to journalArticle

    Open Access
  • Key prognostic factors for EGFR-mutated non-adenocarcinoma lung cancer patients in the Japanese Joint Committee of Lung Cancer Registry Database

    Kobayashi, K., Soejima, K., Fukunaga, K., Shintani, Y., Sekine, I., Shukuya, T., Takayama, K., Inoue, A., Okamoto, I., Kiura, K., Takahashi, K., Yamamoto, N., Takiguchi, Y., Miyaoka, E., Okumura, M. & Yoshino, I., 2020 Aug, In : Lung Cancer. 146, p. 236-243 8 p.

    Research output: Contribution to journalArticle

  • Successful Retreatment Using Pembrolizumab for Non–small-cell Lung Cancer After Severe Immune-related Hepatitis: A Case Report

    Kobayashi, K., Nakachi, I., Mitsuishi, A., Arai, D., Sakurai, K., Masaki, K., Chiyotani, A., Takahashi, H., Tahara, T. & Soejima, K., 2020 Jan, In : Clinical Lung Cancer. 21, 1, p. e30-e32

    Research output: Contribution to journalArticle

    A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients

    Tani, T., Naoki, K., Yasuda, H., Arai, D., Ishioka, K., Ohgino, K., Yoda, S., Nakayama, S., Satomi, R., Terai, H., Ikemura, S., Sato, T. & Soejima, K., 2019 Nov 1, In : Cancer Chemotherapy and Pharmacology. 84, 5, p. 1065-1071 7 p.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)